We live in an interconnected world where the marketplace for all things is global. But we must also make sure the global system works for the benefit of the patients we serve. That includes taking steps to ensure the long-term stability and integrity of our critical pharmaceutical supply chain.
From News&Views: Members of LRAC work to effectively advocate AMCP’s positions on a wide range of current and anticipated state and federal legislative and regulatory issues. AMCP News&Views caught up with committee chair Nisreen Shamseddine to get her perspective on the committee’s goals for this year.
From News&Views: The AMCP Foundation recently welcomed two pharmacist residents, Jared Tate and Emily Tsiao, for a one-month rotation through the Postgraduate Year One (PGY1) Managed Care Residency at Premera Blue Cross in Seattle, Wash.
AMCP CEO Blog: PA is a crucial but often-misunderstood utilization management tool in the pharmacy benefit space. The bad rap that PAs have received recently, I believe, comes from either misinformation about the process or glitches in specific systems that can easily be corrected.
From News&Views April 2019: The Biologics Price Competition and Innovation Act (BPCIA) of 2009 created an FDA approval pathway for biosimilars that aimed to expanded patient access to these more affordable therapies.
AMCP CEO Address: AMCP CEO Susan A. Cantrell, RPh, CAE addressed the AMCP 2019 Annual Meeting on March 26, laying out how AMCP is prepared to meet the challenges of today’s complex health care system. The following is a lightly edited transcript of that address.